Metraipolis › archive › dc_cb01dc29fe02

Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation — Europe PMC PMID:41684593

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41684593
DOI: 10.3389/fonc.2026.1679086
License (as archived): solo-consultazione
Archived: 2026-11-06T11:40:57.635Z
SHA-256 of the archived text: 94664b41550d6453616e5339f503059372438500bda1dcdd27e2a9aa7a444ccb
Stable URL of this page: https://metraipolis.com/documento/dc_cb01dc29fe02

How to cite

Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation — Europe PMC PMID:41684593 — Europe PMC (en), https://europepmc.org/article/MED/41684593 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb01dc29fe02 (Metraipolis archive dc_cb01dc29fe02, sha256 94664b41550d6453616e5339f503059372438500bda1dcdd27e2a9aa7a444ccb)

BibTeX

@misc{dccb01dc29fe02,
  title = {Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation — Europe PMC PMID:41684593},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41684593},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb01dc29fe02; sha256 94664b41550d6453616e5339f503059372438500bda1dcdd27e2a9aa7a444ccb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41684593. Agents can read the archived copy with the MCP tool read_document.